DeutschClear Cookie - decide language by browser settings
Pratschke, Sebastian; Eder, Michael; Heise, Michael; Nadalin, Silvio; Pascher, Andreas; Schemmer, Peter; Scherer, Marcus N.; Ulrich, Frank; Wolters, Heiner; Jauch, Karl-Walter; Wöhling, Dirk; Angele, Martin K.: Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion. In: Transplantation Research 2013, 2:3





Critical organ shortage results in the utilization of extended donor criteria (EDC) liver grafts. These marginal liver grafts are prone to increased ischemia reperfusion injury (IRI) which may contribute to deteriorated graft function and survival. Experimental data have shown that the calcineurin inhibitor tacrolimus exerts protective effects on hepatic IRI when applied intravenously or directly as a hepatic rinse. Therefore, the aim of the present study is to examine the effects of an ex vivo tacrolimus perfusion on IRI in transplantation of EDC liver grafts.